BNTC
Benitec Biopharma Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$11.75
-0.37 ▼ -3.05%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$11.75
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -0.93 | Insider Own | 5.03% | Shs Outstand | 0.03B | Perf Week | 3.62% |
| Market Cap | 0.40B | Forward P/E | - | EPS next Y | 1.77% | Insider Trans | - | Shs Float | 0.03B | Perf Month | 0.86% |
| Enterprise Value | 0.22B | PEG | - | EPS next Q | -0.28 | Inst Own | 93.72% | Short Float | 6.19% | Perf Quarter | -8.27% |
| Income | -0.04B | P/S | - | EPS this Y | -7.62% | Inst Trans | 16.63% | Short Ratio | 11.33 | Perf Half Y | -15.95% |
| Sales | 0.00B | P/B | 2.15 | EPS next 5Y | 5.01% | ROA | -28.89% | Short Interest | 2.02M | Perf YTD | -12.77% |
| Book/sh | 5.47 | P/C | 2.14 | EPS past 3/5Y | 69.76% 62.31% | ROE | -29.59% | 52W High | -31.49% ($17.15) | Perf Year | -20.61% |
| Cash/sh | 5.5 | P/FCF | - | Sales past 3/5Y | - | ROIC | -20.74% | 52W Low | 19.29% ($9.85) | Perf 3Y | 187.99% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 68.74% | Gross Margin | - | Volatility(W/M) | 9.29% 7.81% | Perf 5Y | -78.99% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | -100% | Oper. Margin | - | ATR (14) | 0.84 | Perf 10Y | -97.49% |
| Dividend Ex-Date | - | Quick Ratio | 67.69 | EPS Q/Q | 22.74% | Profit Margin | - | RSI (14) | 52.31 | Recom | 1.17 |
| Dividend Gr. 3/5Y | - | Current Ratio | 67.69 | Sales Q/Q | - | SMA20 | 5.46% ($11.14) | Beta | 0.08 | Target Price | $25.6 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 2000000 | SMA50 | 0.04% ($11.75) | Rel Volume | 0.74 | Prev Close | $12.12 |
| Employees | 19 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -16.44% - | SMA200 | -10.33% ($13.1) | Avg Volume(3M) | 0.18M | Price | $11.75 |
| IPO | 2014/6/23 | Option/Short | Yes/Yes | Trades | 2192 | Volume | 130,994 | Change | -3.05% |
뉴스 로딩 중...